Clinical Trials Insight: 700017309
Phase of Trial: Phase I/II
Latest Information Update: 23 Oct 2008
At a glance
- Drugs KB 3305 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Karo Bio
- 23 Oct 2008 Status changed from active, no longer recruiting to completed, as reported in a Karo Bio media release.
- 23 Oct 2008 Results data reported in a Karo Bio media release.
- 17 Apr 2008 Patient dosing completed, according to a Karo Bio media release.